Evidence map›Paper›PMID 37230984›Full record

Trial reportTranslational psychiatry2023

Amygdala downregulation training using fMRI neurofeedback in post-traumatic stress disorder: a randomized, double-blind trial.

Zhiying Zhao, Or Duek, Rebecca Seidemann, Charles Gordon, Christopher Walsh, Emma Romaker, William N Koller, Mark Horvath, Jitendra Awasthi, Yao Wang and 4 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Translational psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Neurorights in the Constitution: from neurotechnology to ethics and politics.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Zhiying ZhaoCentre for Cognitive and Brain Sciences, University of Macau, Macau SAR, China.ORCID 0000-0002-0369-1308
Or DuekDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.ORCID 0000-0001-5211-7946
Rebecca SeidemannDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Charles GordonDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Christopher WalshDepartment of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Emma RomakerDepartment of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
William N KollerDepartment of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Mark HorvathDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Jitendra AwasthiDepartment of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
Yao WangCentre for Cognitive and Brain Sciences, University of Macau, Macau SAR, China.
Erin O'BrienDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Harlan FichtenholtzDepartment of Psychiatry, Yale University School of Medicine, New Haven, CT, USA.
Michelle Hampson *Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA. michelle.hampson@yale.edu.ORCID 0000-0003-3173-4210
Ilan Harpaz-Rotem *Department of Psychiatry, Yale University School of Medicine, New Haven, CT, USA. ilan.harpaz-rotem@yale.edu.ORCID 0000-0002-6066-9406
Yale University · USUniversity of Macau · MOKeene State College · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Neurofeedback of amygdala activity for PTSDR61MH115110 · NIMH · YALE UNIVERSITY · PI HAMPSON, MICHELLE, HARPAZ-ROTEM, ILAN · 2018 to 2021
$1.2M
NCATS NIH HHS UL1 TR001863NIMH NIH HHS R61 MH115110
6 · The paper itself

Abstract

Hyperactivation of amygdala is a neural marker for post-traumatic stress disorder (PTSD) and improvement in control over amygdala activity has been associated with treatment success in PTSD. In this randomized, double-blind clinical trial we evaluated the efficacy of a real-time fMRI neurofeedback intervention designed to train control over amygdala activity following trauma recall. Twenty-five patients with PTSD completed three sessions of neurofeedback training in which they attempted to downregulate the feedback signal after exposure to personalized trauma scripts. For subjects in the active experimental group (N = 14), the feedback signal was from a functionally localized region of their amygdala associated with trauma recall. For subjects in the control group (N = 11), yoked-sham feedback was provided. Changes in control over the amygdala and PTSD symptoms served as the primary and secondary outcome measurements, respectively. We found significantly greater improvements in control over amygdala activity in the active group than in the control group 30-days following the intervention. Both groups showed improvements in symptom scores, however the symptom reduction in the active group was not significantly greater than in the control group. Our finding of greater improvement in amygdala control suggests potential clinical application of neurofeedback in PTSD treatment. Thus, further development of amygdala neurofeedback training in PTSD treatment, including evaluation in larger samples, is warranted.

Indexed as

NeurofeedbackStress Disorders, Post-TraumaticAmygdalaDown-RegulationHumansMagnetic Resonance Imaging

Identifiers

PMID37230984
PMCPMC10209552
OpenAlexW4378227164

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.